STAT5 activity in pancreatic β-cells

References

• Gouilleux F, Moritz D, Humar M et al. Prolactin and interleukin-2 receptors in T lymphocytes signal through a MGF–STAT5-like transcription factor. Endocrinology136(12), 5700–5708 (1995).
   PubMed Web of Science ®Google Scholar
• Schindler C, Levy DE, Decker T. JAK–STAT signaling: from interferons to cytokines. J. Biol. Chem.282(28), 20059–20063 (2007).
   PubMed Web of Science ®Google Scholar
• Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE Jr. ISGF3, the transcriptional activator induced by interferon-α, consists of multiple interacting polypeptide chains. Proc. Natl Acad. Sci. USA87(21), 8555–8559 (1990).
   PubMed Web of Science ®Google Scholar
• Wakao H, Schmitt-Ney M, Groner B. Mammary gland-specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 κDa. J. Biol. Chem.267(23), 16365–16370 (1992).
   PubMedGoogle Scholar
• Schmitt-Ney M, Happ B, Hofer P, Hynes NE, Groner B. Mammary gland-specific nuclear factor activity is positively regulated by lactogenic hormones and negatively by milk stasis. Mol. Endocrinol.6(12), 1988–1997 (1992).
   PubMedGoogle Scholar
• Schmitt-Ney M, Happ B, Ball RK, Groner B. Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding β-casein. Proc. Natl Acad. Sci. USA89(7), 3130–3134 (1992).
   PubMed Web of Science ®Google Scholar
• Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl Acad. Sci. USA92(19), 8831–8835 (1995).
   PubMedGoogle Scholar
• Miyoshi K, Cui Y, Riedlinger G et al. Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. Genomics71(2), 150–155 (2001).
   PubMedGoogle Scholar
• Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci.25(10), 496–502 (2000).
   PubMed Web of Science ®Google Scholar
• Brelje TC, Stout LE, Bhagroo NV, Sorenson RL. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans. Endocrinology145(9), 4162–4175 (2004).
   PubMed Web of Science ®Google Scholar
• Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans. J. Histochem. Cytochem.50(3), 365–383 (2002).
   PubMed Web of Science ®Google Scholar
• Su AI, Cooke MP, Ching KA et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl Acad. Sci. USA99(7), 4465–4470 (2002).
   PubMed Web of Science ®Google Scholar
• Su AI, Wiltshire T, Batalov S et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA101(16), 6062–6067 (2004).
   PubMed Web of Science ®Google Scholar
• Liu JL, Coschigano KT, Robertson K et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol Endocrinol. Metab.287(3), E405–E413 (2004).
   PubMedGoogle Scholar
• Gadina M, Hilton D, Johnston JA et al. Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol.13(3), 363–373 (2001).
   PubMed Web of Science ®Google Scholar
• Sotiropoulos A, Moutoussamy S, Renaudie F et al. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol.10(8), 998–1009 (1996)
   PubMedGoogle Scholar
• Hansen JA, Hansen LH, Wang X et al. The role of GH receptor tyrosine phosphorylation in Stat5 activation. J. Mol. Endocrinol.18(3), 213–221 (1997).
   PubMedGoogle Scholar
• Campbell GS. Growth-hormone signal transduction. J. Pediatr.131(1 Pt 2), S42–S44 (1997)
   Google Scholar
• Lebrun JJ, Ali S, Sofer L, Ullrich A, Kelly PA. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem.269(19), 14021–14026 (1994).
   PubMedGoogle Scholar
• Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J.14(11), 2527–2535 (1995).
   PubMedGoogle Scholar
• Mui AL, Wakao H, O’Farrell AM, Harada N, Miyajima A. Interleukin-3, granulocyte–macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J.14(6), 1166–1175 (1995).
   PubMed Web of Science ®Google Scholar
• Chen X, Vinkemeier U, Zhao Y et al. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell93(5), 827–839 (1998).
   PubMed Web of Science ®Google Scholar
• Herrington J, Rui L, Luo G, Yu-Lee LY, Carter-Su C. A functional DNA binding domain is required for growth hormone-induced nuclear accumulation of Stat5B. J. Biol. Chem.274(8), 5138–5145 (1999).
   PubMed Web of Science ®Google Scholar
• Ihle JN. The Stat family in cytokine signaling. Curr. Opin. Cell Biol.13(2), 211–217 (2001).
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STATs and gene regulation. Science277(5332), 1630–1635 (1997).
   PubMed Web of Science ®Google Scholar
• Beuvink I, Hess D, Flotow H et al. Stat5a serine phosphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated n vitro DNA binding activity. J. Biol. Chem.275(14), 10247–10255 (2000).
   PubMedGoogle Scholar
• Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene19(21), 2628–2637 (2000).
   PubMed Web of Science ®Google Scholar
• McCubrey JA, May WS, Duronio V, Mufson A. Serine/threonine phosphorylation in cytokine signal transduction. Leukemia14(1), 9–21 (2000).
   PubMed Web of Science ®Google Scholar
• Horvai AE, Xu L, Korzus E et al. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl Acad. Sci. USA94(4), 1074–1079 (1997).
   PubMedGoogle Scholar
• Torchia J, Glass C, Rosenfeld MG. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell Biol.10(3), 373–383 (1998).
   PubMed Web of Science ®Google Scholar
• Pfitzner E, Jahne R, Wissler M, Stoecklin E, Groner B. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol.12(10), 1582–1593 (1998).
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Vinkemeier U, Gu W et al. Two contact regions between Stat1 and CBP/p300 in interferon-γ signaling. Proc. Natl Acad. Sci. USA93(26), 15092–15096 (1996).
   PubMed Web of Science ®Google Scholar
• Gewinner C, Hart G, Zachara N et al. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5. J. Biol. Chem.279(5), 3563–3572 (2004).
   PubMed Web of Science ®Google Scholar
• Onishi M, Nosaka T, Misawa K et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell Biol.18(7), 3871–3879 (1998).
   PubMed Web of Science ®Google Scholar
• Ariyoshi K, Nosaka T, Yamada K et al. Constitutive activation of STAT5 by a point mutation in the SH2 domain. J. Biol. Chem.275(32), 24407–24413 (2000).
   PubMed Web of Science ®Google Scholar
• Moriggl R, Gouilleux-Gruart V, Jahne R et al. Deletion of the carboxyl-terminal transactivation domain of MGF–Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell Biol.16(10), 5691–5700 (1996).
   PubMed Web of Science ®Google Scholar
• Mui AL, Wakao H, Kinoshita T, Kitamura T, Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J.15(10), 2425–2433 (1996).
   PubMed Web of Science ®Google Scholar
• Friedrichsen BN, Galsgaard ED, Nielsen JH, Moldrup A. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). Mol. Endocrinol.15(1), 136–148 (2001).
   PubMedGoogle Scholar
• Friedrichsen BN, Richter HE, Hansen JA et al. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β–cells. Mol. Endocrinol.17(5), 945–958 (2003).
   PubMed Web of Science ®Google Scholar
• Jensen J, Galsgaard ED, Karlsen AE, Lee YC, Nielsen JH. STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production. J. Endocrinol.187(1), 25–36 (2005).
   PubMedGoogle Scholar
• Jackerott M, Moldrup A, Thams P et al. STAT5 activity in pancreatic β-cells influences the severity of diabetes in animal models of Type 1 and 2 diabetes. Diabetes55(10), 2705–2712 (2006).
   PubMedGoogle Scholar
• Nielsen JH, Galsgaard ED, Moldrup A et al. Regulation of β-cell mass by hormones and growth factors. Diabetes50(Suppl. 1), S25–S29 (2001).
   PubMed Web of Science ®Google Scholar
• Cousin SP, Hugl SR, Myers MG Jr et al. Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Biochem. J.344(Pt 3), 649–658 (1999).
   PubMed Web of Science ®Google Scholar
• Winston LA, Bertics P J. Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J. Biol. Chem.267(7), 4747–4751 (1992).
   PubMedGoogle Scholar
• Campbell GS, Pang L, Miyasaka T, Saltiel AR, Carter-Su C. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts. J. Biol. Chem.267(9), 6074–6080 (1992).
   PubMedGoogle Scholar
• Billestrup N, Hansen JA, Hansen LH et al. Molecular mechanism of growth hormone signalling. Endocr. J.45(Suppl.), S41–S45 (1998).
   Google Scholar
• VanderKuur JA, Wang X, Zhang L et al. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J. Biol. Chem.270(37), 21738–21744 (1995).
   PubMedGoogle Scholar
• Argetsinger LS, Hsu GW, Myers MG Jr et al. Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem.270(24), 14685–14692 (1995).
   PubMedGoogle Scholar
• Thirone AC, Carvalho CR, Brenelli SL, Velloso LA, Saad MJ. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues. Mol. Cell Endocrinol.130(1–2), 33–42 (1997).
   PubMedGoogle Scholar
• Oberbauer AM, Peng R. Fractionation of growth plate chondrocytes: differential expression of IGF-I and growth hormone and IGF-I receptor mRNA in purified populations. Connect. Tissue Res.31(3), 179–187 (1995).
   PubMed Web of Science ®Google Scholar
• Nielsen JH, Linde S, Welinder BS, Billestrup N, Madsen OD. Growth hormone is a growth factor for the differentiated pancreatic β-cell. Mol. Endocrinol.3(1), 165–173 (1989).
   PubMedGoogle Scholar
• Billestrup N, Nielsen JH. The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I. Endocrinology129(2), 883–888 (1991).
   PubMedGoogle Scholar
• Billestrup N, Martin JM. Growth hormone binding to specific receptors stimulates growth and function of cloned insulin-producing rat insulinoma RIN-5AH cells. Endocrinology116(3), 1175–1181 (1985).
   PubMedGoogle Scholar
• Wabitsch M, Heinze E, Hauner H et al. Biological effects of human growth hormone in rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism45(1), 34–42 (1996).
   PubMedGoogle Scholar
• Ledet T. Growth hormone stimulating the growth of arterial medial cells in vitro. Absence of effect of insulin. Diabetes25(11), 1011–1017 (1976).
   PubMed Web of Science ®Google Scholar
• Gronowski AM, Zhong Z, Wen Z et al. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3. Mol. Endocrinol.9(2), 171–177 (1995).
   PubMedGoogle Scholar
• Wood TJ, Sliva D, Lobie PE et al. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J. Biol. Chem.270(16), 9448–9453 (1995).
   PubMedGoogle Scholar
• Amaral ME, Ueno M, Carvalheira JB et al. Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Horm. Metab. Res.35(5), 282–289 (2003).
   PubMedGoogle Scholar
• Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev.19(3), 225–268 (1998).
   PubMed Web of Science ®Google Scholar
• Amaral ME, Cunha DA, Anhe GF et al. Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy. J. Endocrinol.183(3), 469–476 (2004).
   PubMed Web of Science ®Google Scholar
• Galsgaard ED, Gouilleux F, Groner B et al. Identification of a growth hormone-responsive STAT5-binding element in the rat insulin 1 gene. Mol. Endocrinol.10(6), 652–660 (1996).
   PubMedGoogle Scholar
• Ehret GB, Reichenbach P, Schindler U et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem.276(9), 6675–6688 (2001).
   PubMed Web of Science ®Google Scholar
• Meyer DJ, Stephenson EW, Johnson L, Cochran BH, Schwartz J. The serum response element can mediate induction of c-fos by growth hormone. Proc. Natl Acad. Sci. USA90(14), 6721–6725 (1993).
   PubMedGoogle Scholar
• Chen C, Clarkson RW, Xie Y, Hume DA, Waters MJ. Growth hormone and colony-stimulating factor 1 share multiple response elements in the c-fos promoter. Endocrinology136(10), 4505–4516 (1995).
   PubMedGoogle Scholar
• John S, Vinkemeier U, Soldaini E, Darnell JE Jr, Leonard WJ. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell Biol.19(3), 1910–1918 (1999).
   PubMed Web of Science ®Google Scholar
• Soldaini E, John S, Moro S et al. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell Biol.20(1), 389–401 (2000).
   PubMedGoogle Scholar
• LeBaron MJ, Xie J, Rui H. Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer. Mol. Cancer4(1), 6 (2005).
   PubMedGoogle Scholar
• Clarkson RW, Boland MP, Kritikou EA et al. The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol. Endocrinol.20(3), 675–685 (2006).
   PubMedGoogle Scholar
• Gass S, Harris J, Ormandy C, Brisken C. Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function. J. Mammary Gland. Biol. Neoplasia8(3), 269–285 (2003).
   PubMedGoogle Scholar
• Bole-Feysot C, Perret E, Roustan P, Bouchard B, Kelly PA. Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques. Genome Biol.1(4), RESEARCH0008 (2000).
   PubMedGoogle Scholar
• Clodfelter KH, Miles GD, Wauthier V et al. Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis. Physiol. Genomics31(1), 63–74 (2007).
   PubMed Web of Science ®Google Scholar
• Clodfelter KH, Holloway MG, Hodor P et al. Sex-dependent liver gene expression is extensive and largely dependent upon signal transducer and activator of transcription 5b (STAT5b): STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol. Endocrinol.20(6), 1333–1351 (2006).
   PubMedGoogle Scholar
• Vidal OM, Merino R, Rico-Bautista E et al.In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. Mol. Endocrinol.21(1), 293–311 (2007).
   PubMedGoogle Scholar
• Bordin S, Amaral ME, Anhe GF et al. Prolactin-modulated gene expression profiles in pancreatic islets from adult female rats. Mol. Cell Endocrinol.220(1–2), 41–50 (2004).
   PubMedGoogle Scholar
• Karnik SK, Chen H, McLean GW et al. Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus. Science318(5851), 806–809 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson EA, Walker SR, Alvarez JV, Frank DA. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J. Biol. Chem.279(52), 54724–54730 (2004).
   PubMed Web of Science ®Google Scholar
• Walton KD, Wagner KU, Rucker EB III et al. Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. Mech. Dev.109(2), 281–293 (2001).
   PubMedGoogle Scholar
• Dolznig H, Grebien F, Deiner EM et al. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene25(20), 2890–2900 (2006).
   PubMedGoogle Scholar
• Brelje TC, Scharp DW, Lacy PE et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet β-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology132(2), 879–887 (1993).
   PubMed Web of Science ®Google Scholar
• Brelje TC, Allaire P, Hegre O, Sorenson RL. Effect of prolactin versus growth hormone on islet function and the importance of using homologous mammosomatotropic hormones. Endocrinology125(5), 2392–2399 (1989).
   PubMedGoogle Scholar
• Galsgaard ED, Nielsen JH, Moldrup A. Regulation of prolactin receptor (PRLR) gene expression in insulin-producing cells. Prolactin and growth hormone activate one of the rat prlr gene promoters via STAT5a and STAT5b. J. Biol. Chem.274(26), 18686–18692 (1999).
   PubMed Web of Science ®Google Scholar
• Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL. Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy. J. Endocrinol.193(3), 367–381 (2007).
   PubMed Web of Science ®Google Scholar
• Crepaldi-Alves SC, Carneiro EM, Bosqueiro JR, Boschero AC. Synergistic effect of glucose and prolactin on GLUT2 expression in cultured neonatal rat islets. Braz. J. Med. Biol. Res.30(3), 359–361 (1997).
   PubMedGoogle Scholar
• Petryk A, Fleenor D, Driscoll P, Freemark M. Prolactin induction of insulin gene expression: the roles of glucose and glucose transporter-2. J. Endocrinol.164(3), 277–286 (2000).
   PubMed Web of Science ®Google Scholar
• Fujinaka Y, Takane K, Yamashita H, Vasavada RC. Lactogens promote β-cell survival through JAK2/STAT5 activation and Bcl-XL upregulation. J. Biol. Chem.282(42), 30707–30717 (2007).
   PubMedGoogle Scholar
• Karnik SK, Hughes CM, Gu X et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl Acad. Sci. USA102(41), 14659–14664 (2005).
   PubMed Web of Science ®Google Scholar
• Mziaut H, Trajkovski M, Kersting S et al. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nat. Cell Biol.8(5), 435–445 (2006).
   PubMed Web of Science ®Google Scholar
• Mziaut H, Kersting S, Knoch KP et al. ICA512 signaling enhances pancreatic β-cell proliferation by regulating cyclins D through STATs. Proc. Natl Acad. Sci. USA105(2), 674–679 (2008).
   PubMedGoogle Scholar
• Klampfer L. Signal transducers and activators of transcription (STATs): novel targets of chemopreventive and chemotherapeutic drugs. Curr. Cancer Drug Targets.6(2), 107–121 (2006).
   PubMed Web of Science ®Google Scholar
• Shuai K. Modulation of STAT signaling by STAT-interacting proteins. Oncogene19(21), 2638–2644 (2000).
   PubMed Web of Science ®Google Scholar
• Gingras S, Simard J, Groner B, Pfitzner E. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res.27(13), 2722–2729 (1999).
   PubMedGoogle Scholar
• Zhu M, John S, Berg M, Leonard WJ. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-mediated signaling. Cell96(1), 121–130 (1999).
   PubMed Web of Science ®Google Scholar
• Litterst CM, Kliem S, Marilley D, Pfitzner E. NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the α-helical region of the STAT5 transactivation domain. J. Biol. Chem.278(46), 45340–45351 (2003).
   PubMed Web of Science ®Google Scholar
• Guenther MG, Barak O, Lazar MA. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell Biol.21(18), 6091–6101 (2001).
   PubMed Web of Science ®Google Scholar
• Nakajima H, Brindle PK, Handa M, Ihle JN. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J.20(23), 6836–6844 (2001).
   PubMedGoogle Scholar
• Lin JX, Leonard WJ. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene19(21), 2566–2576 (2000).
   PubMed Web of Science ®Google Scholar
• Rascle A, Lees E. Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription. Nucleic Acids Res.31(23), 6882–6890 (2003).
   PubMedGoogle Scholar
• Rascle A, Johnston JA, Amati B. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol. Cell Biol.23(12), 4162–4173 (2003).
   PubMed Web of Science ®Google Scholar
• Nusinzon I, Horvath CM. Unexpected roles for deacetylation in interferon- and cytokine-induced transcription. J. Interferon Cytokine Res.25(12), 745–748 (2005).
   PubMedGoogle Scholar
• Nusinzon I, Horvath CM. Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci. STKE 2005(296), re11 (2005).
   PubMedGoogle Scholar
• Nusinzon I, Horvath CM. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl Acad. Sci. USA100(25), 14742–14747 (2003).
   PubMed Web of Science ®Google Scholar
• Walker SR, Nelson EA, Frank DA. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene26(2), 224–233 (2007).
   PubMed Web of Science ®Google Scholar
• Scheeren FA, Naspetti M, Diehl S et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol.6(3), 303–313 (2005).
   PubMed Web of Science ®Google Scholar
• Hogan JC, Stephens JM. The regulation of fatty acid synthase by STAT5A. Diabetes54(7), 1968–1975 (2005).
   PubMedGoogle Scholar
• Stoecklin E, Wissler M, Schaetzle D, Pfitzner E, Groner B. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J. Steroid Biochem. Mol. Biol.69(1–6), 195–204 (1999).
   PubMed Web of Science ®Google Scholar
• Delesque-Touchard N, Park SH, Waxman DJ. Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver. J. Biol. Chem.275(44), 34173–34182 (2000).
   PubMed Web of Science ®Google Scholar
• Zhou YC, Waxman DJ. Cross-talk between Janus kinase-signal transducer and activator of transcription (JAK–STAT) and peroxisome proliferator-activated receptor-α (PPARα) signaling pathways. Growth hormone inhibition of ppara transcriptional activity mediated by Stat5b. J. Biol. Chem.274(5), 2672–2681 (1999).
   PubMedGoogle Scholar
• Zhou YC, Waxman DJ. STAT5b down-regulates peroxisome proliferator-activated receptor-α transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. J. Biol. Chem.274(42), 29874–29882 (1999).
   PubMed Web of Science ®Google Scholar
• Luo G, Yu-Lee L. Stat5b inhibits NFκB-mediated signaling. Mol. Endocrinol.14(1), 114–123 (2000).
   PubMedGoogle Scholar
• Nanbu-Wakao R, Morikawa Y, Matsumura I et al. Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5. Mol. Endocrinol.16(7), 1565–1576 (2002).
   PubMedGoogle Scholar
• Shipley JM, Waxman DJ. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Toxicol. Appl. Pharmacol.199(3), 275–284 (2004).
   PubMedGoogle Scholar
• Shipley JM, Waxman DJ. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR)-α and PPARγ. Mol. Pharmacol.64(2), 355–364 (2003).
   PubMed Web of Science ®Google Scholar
• Park SH, Waxman DJ. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3β: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J. Biol. Chem.276(46), 43031–43039 (2001).
   PubMed Web of Science ®Google Scholar
• Park SH, Wiwi CA, Waxman DJ. Signalling cross-talk between hepatocyte nuclear factor 4α and growth-hormone-activated STAT5b. Biochem. J.397(1), 159–168 (2006).
   PubMedGoogle Scholar
• Luo G, Yu-Lee L. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters. J. Biol. Chem.272(43), 26841–26849 (1997).
   PubMedGoogle Scholar
• Bromberg JF. Activation of STAT proteins and growth control. Bioessays23(2), 161–169 (2001).
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Wrzeszczynska MH, Devgan G et al. Stat3 as an oncogene. Cell98(3), 295–303 (1999).
   PubMed Web of Science ®Google Scholar
• Jiao H, Berrada K, Yang W et al. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell Biol.16(12), 6985–6992 (1996).
   PubMed Web of Science ®Google Scholar
• Kashiwada M, Giallourakis CC, Pan PY, Rothman PB. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation. J. Immunol.167(11), 6382–6387 (2001).
   PubMedGoogle Scholar
• Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell80(5), 729–738 (1995).
   PubMed Web of Science ®Google Scholar
• Neel BG, Gu H, Pao L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci.28(6), 284–293 (2003).
   PubMed Web of Science ®Google Scholar
• Irie-Sasaki J, Sasaki T, Matsumoto W et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature409(6818), 349–354 (2001).
   PubMed Web of Science ®Google Scholar
• Aoki N, Matsuda T. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b. J. Biol. Chem.275(50), 39718–39726 (2000).
   PubMedGoogle Scholar
• Lund IK, Hansen JA, Andersen HS, Moller NP, Billestrup N. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J. Mol. Endocrinol.34(2), 339–351 (2005).
   PubMedGoogle Scholar
• Yamamoto T, Sekine Y, Kashima K et al. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun.297(4), 811–817 (2002).
   PubMed Web of Science ®Google Scholar
• Ten HJ, De JI, Fu Y et al. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell Biol.22(16), 5662–5668 (2002).
   PubMed Web of Science ®Google Scholar
• Aoki N, Matsuda T. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol.16(1), 58–69 (2002).
   PubMedGoogle Scholar
• Liu B, Liao J, Rao X et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl Acad. Sci. USA95(18), 10626–10631 (1998).
   PubMed Web of Science ®Google Scholar
• Chung CD, Liao J, Liu B et al. Specific inhibition of Stat3 signal transduction by PIAS3. Science278(5344), 1803–1805 (1997).
   PubMed Web of Science ®Google Scholar
• Rogers RS, Horvath CM, Matunis MJ. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation. J. Biol. Chem.278(32), 30091–30097 (2003)
   PubMedGoogle Scholar
• Mowen KA, Tang J, Zhu W et al. Arginine methylation of STAT1 modulates IFNα/β-induced transcription. Cell104(5), 731–741 (2001).
   PubMed Web of Science ®Google Scholar
• Ronn SG, Billestrup N, Mandrup-Poulsen T. Diabetes and suppressors of cytokine signaling proteins. Diabetes56(2), 541–548 (2007).
   PubMed Web of Science ®Google Scholar
• Starr R, Hilton DJ. SOCS: suppressors of cytokine signalling. Int. J. Biochem. Cell Biol.30(10), 1081–1085 (1998).
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Ohkubo T, Kiguchi T et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J.14(12), 2816–2826 (1995).
   PubMed Web of Science ®Google Scholar
• Greenhalgh CJ, Metcalf D, Thaus AL et al. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J. Biol. Chem.277(43), 40181–40184 (2002).
   PubMed Web of Science ®Google Scholar
• Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol.13(11), 1832–1843 (1999).
   PubMedGoogle Scholar
• Ram PA, Waxman DJ. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J. Biol. Chem.274(50), 35553–35561 (1999).
   PubMed Web of Science ®Google Scholar
• Ram PA, Waxman DJ. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J. Biol. Chem.275(50), 39487–39496 (2000).
   PubMed Web of Science ®Google Scholar
• Karlsson H, Gustafsson JA, Mode A. Cis desensitizes GH induced Stat5 signaling in rat liver cells. Mol. Cell Endocrinol.154(1–2), 37–43 (1999).
   PubMedGoogle Scholar
• Adams TE, Hansen JA, Starr R et al. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem.273(3), 1285–1287 (1998).
   PubMedGoogle Scholar
• Chong MM, Thomas HE, Kay TW. γ-interferon signaling in pancreatic β-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1. Diabetes50(12), 2744–2751 (2001).
   PubMedGoogle Scholar
• Ronn SG, Hansen JA, Lindberg K, Karlsen AE, Billestrup N. The effect of suppressor of cytokine signaling 3 on GH signaling in β-cells. Mol. Endocrinol.16(9), 2124–2134 (2002).
   PubMedGoogle Scholar
• Karlsen AE, Heding PE, Frobose H et al. Suppressor of cytokine signalling (SOCS)-3 protects β-cells against IL-1β-mediated toxicity through inhibition of multiple nuclear factor-κB-regulated proapoptotic pathways. Diabetologie47(11), 1998–2011 (2004).
   PubMedGoogle Scholar
• Karlsen AE, Ronn SG, Lindberg K et al. Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin-1β- and interferon-γ-mediated toxicity. Proc. Natl Acad. Sci. USA98(21), 12191–12196 (2001).
   PubMed Web of Science ®Google Scholar
• Moldrup A, Petersen ED, Nielsen JH. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology133(3), 1165–1172 (1993).
   PubMed Web of Science ®Google Scholar
• Parsons JA, Brelje TC, Sorenson RL. Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology130(3), 1459–1466 (1992).
   PubMed Web of Science ®Google Scholar
• Carlsson C, Tornehave D, Lindberg K et al. Growth hormone and prolactin stimulate the expression of rat preadipocyte factor-1/δ-like protein in pancreatic islets: molecular cloning and expression pattern during development and growth of the endocrine pancreas. Endocrinology138(9), 3940–3948 (1997).
   PubMed Web of Science ®Google Scholar
• Jackerott M, Lee YC, Mollgard K et al. Trefoil factors are expressed in human and rat endocrine pancreas: differential regulation by growth hormone. Endocrinology147(12), 5752–5759 (2006).
   PubMed Web of Science ®Google Scholar
• Fueger PT, Schisler JS, Lu D et al. Trefoil factor 3 stimulates human and rodent pancreatic islet β-cell replication with retention of function. Mol. Endocrinol.22(5), 1251–1259 (2008).
   PubMedGoogle Scholar
• Sekine N, Fukumoto S, Ishikawa T, Okazaki T, Fujita T. GH inhibits interferon-γ-induced signal transducer and activator of transcription-1 activation and expression of the inducible isoform of nitric oxide synthase in INS-1 cells. Endocrinology142(9), 3909–3916 (2001).
   PubMedGoogle Scholar
• Teglund S, McKay C, Schuetz E et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell93(5), 841–850 (1998).
   PubMed Web of Science ®Google Scholar
• Udy GB, Towers RP, Snell RG et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl Acad. Sci. USA94(14), 7239–7244 (1997).
   PubMed Web of Science ®Google Scholar
• Liu X, Robinson GW, Wagner KU et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev.11(2), 179–186 (1997).
   PubMed Web of Science ®Google Scholar
• Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J. Leukoc. Biol.70(3), 348–356 (2001).
   PubMed Web of Science ®Google Scholar
• Moriggl R, Sexl V, Kenner L et al. Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell7(1), 87–99 (2005).
   PubMed Web of Science ®Google Scholar
• Yao Z, Cui Y, Watford WT et al. Stat5a/b are essential for normal lymphoid development and differentiation. Proc. Natl Acad. Sci. USA103(4), 1000–1005 (2006).
   PubMed Web of Science ®Google Scholar
• Cui Y, Riedlinger G, Miyoshi K et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell Biol.24(18), 8037–8047 (2004).
   PubMed Web of Science ®Google Scholar
• Socolovsky M, Nam H, Fleming MD et al. Ineffective erythropoiesis in Stat5a-/-5b-/- mice due to decreased survival of early erythroblasts. Blood98(12), 3261–3273 (2001).
   PubMed Web of Science ®Google Scholar
• Lee JY, Gavrilova O, Davani B et al. The transcription factors Stat5a/b are not required for islet development but modulate pancreatic β-cell physiology upon aging. Biochim. Biophys. Acta1773(9), 1455–1461 (2007).
   PubMedGoogle Scholar
• Lee JY, Ristow M, Lin X et al. RIP–Cre revisited, evidence for impairments of pancreatic β-cell function. J. Biol. Chem.281(5), 2649–2653 (2006).
   PubMed Web of Science ®Google Scholar
• Gorogawa S, Fujitani Y, Kaneto H et al. Insulin secretory defects and impaired islet architecture in pancreatic β-cell-specific STAT3 knockout mice. Biochem. Biophys. Res. Commun.319(4), 1159–1170 (2004).
   PubMedGoogle Scholar
• Lee JY, Hennighausen L. The transcription factor Stat3 is dispensable for pancreatic β-cell development and function. Biochem. Biophys. Res. Commun.334(3), 764–768 (2005).
   PubMed Web of Science ®Google Scholar
• Anhe GF, Nogueira TC, Nicoletti-Carvalho JE et al. Signal transducer and activator of transcription 3-regulated sarcoendoplasmic reticulum Ca2+-ATPase 2 expression by prolactin and glucocorticoids is involved in the adaptation of insulin secretory response during the peripartum period. J. Endocrinol.195(1), 17–27 (2007).
   PubMedGoogle Scholar
• Morioka T, Asilmaz E, Hu J et al. Disruption of leptin receptor expression in the pancreas directly affects β-cell growth and function in mice. J. Clin. Invest.117(10), 2860–2868 (2007).
   PubMedGoogle Scholar
• Bunting KD. STAT5 signaling in normal and pathologic hematopoiesis. Front. Biosci.12, 2807–2820 (2007).
   PubMedGoogle Scholar
• Fleenor D, Petryk A, Driscoll P, Freemark M. Constitutive expression of placental lactogen in pancreatic β-cells: effects on cell morphology, growth, and gene expression. Pediatr. Res.47(1), 136–142 (2000).
   PubMedGoogle Scholar
• Lindberg K, Ronn SG, Tornehave D et al. Regulation of pancreatic β-cell mass and proliferation by SOCS-3. J. Mol. Endocrinol.35(2), 231–243 (2005).
   PubMedGoogle Scholar
• Mazancourt P, Carneiro EM, Atwater I, Boschero AC. Prolactin treatment increases GLUT2 but not the G protein subunit content in cell membranes from cultured neonatal rat islets. FEBS Lett.343(2), 137–140 (1994).
   PubMedGoogle Scholar